MedInfo World

Empowering patients through shared knowledge and community-driven health insights.

Platform

Drug Information
Health Conditions
Active Ingredients

Support

Help Center
Terms of Use
Privacy Policy
Disclaimer

Company

About Us
Contact

Medical Disclaimer

The information on this website is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Terms Privacy Disclaimer

Ibalizumab – Uses, Side Effects, Dosage & Drug Information | MedInfo World | MedInfo World

Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.

Home Active IngredientsIbalizumab

Ibalizumab

CD4-directed Blocking Antibody [EPC]

1 Drug1 Variant

Clinical Data

Name

Ibalizumab

Raw Name

IBALIZUMAB

Drug Classes

CD4-directed Blocking Antibody [EPC]Human Immunodeficiency Virus 1 Post-attachment Fusion Inhibitor [EPC]

Important Notice

This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Ibalizumab.

Mechanism of Action

CD4-directed Antibody Interactions [MoA]HIV 1 Post-attachment Fusion Inhibitors [MoA]

Chemical Structure

Antibodies, Monoclonal, Humanized [CS]

Identifiers

RxCUI

2043317, 2043322

UNII

LT369U66CE

Drugs with Ibalizumab

Medications containing this ingredient

Trogarzo